Garry Arthur Neil, CSO at Aevi Genomic Medicine, holds 60.00 shares in Avalo Therapeutics (Ticker: AVTX), holds 0.00 shares in Arena Pharma (Ticker: ARNA), holds 2.16M shares in Aevi Genomic Medicine (Ticker: GNMX).
What is the percentage of profitable transactions made by Garry Arthur Neil?
The percentage of profitable transactions made by Garry Arthur Neil is 33%.
What is the average return per transaction made by Garry Arthur Neil?
The average return per transaction made by Garry Arthur Neil is 11.00%.
What stocks does Garry Arthur Neil hold?
Garry Arthur Neil holds: GNMX, ONCT, ARNA, AVTX, CLDX, ZURA stocks.
What was Garry Arthur Neil’s latest transaction?
Garry Arthur Neil latest transaction was an Uninformative Buy of $13.68K.
What was Garry Arthur Neil's most profitable transaction?
Garry Arthur Neil’s most profitable transaction was an Informative Buy of GNMX stock on December 1, 2014. The return on the trade was 61.90%.
What is Garry Arthur Neil's role in Aevi Genomic Medicine?
Garry Arthur Neil's role in Aevi Genomic Medicine is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.